ANI Pharmaceuticals, Inc. (ANIP)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 67.11 |
| 開市 | 67.87 |
| 買盤 | 67.01 x 100 |
| 賣出價 | 67.46 x 100 |
| 今日波幅 | 66.65 - 67.87 |
| 52 週波幅 | 38.91 - 70.81 |
| 成交量 | |
| 平均成交量 | 146,040 |
| 市值 | 1.411B |
| Beta 值 (5 年，每月) | 0.80 |
| 市盈率 (最近 12 個月) | 79.12 |
| 每股盈利 (最近 12 個月) | 0.85 |
| 業績公佈日 | 2024年5月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 79.80 |
ZacksAgios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Agios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark, revenues from its sole marketed drug, Pyrukynd, rise sequentially and on a yearly basis.
ZacksANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksBlueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Blueprint (BPMC) gains from better-than-expected first-quarter 2024 results, driven by robust Ayvakit sales growth. The company raises its revenue guidance for 2024.
